Remedium Bio logo
Healthcare & Life Sciences

Remedium Bio

Remedium Bio is a Healthcare & Life Sciences startup based in the United States, most recent round Series A, 2 tracked investors.

Activeseries-a
series-a
Stage
2
Investors

About Remedium Bio

Remedium Bio is a company headquartered in the United States. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.

Remedium Bio develops gene therapy treatments using a proprietary platform that enables subcutaneous delivery of adjustable dose gene therapies targeting endocrinology, neurology, and rheumatology diseases.

Explore Remedium Bio's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

Other Startups in United States